SIMeL, Società Italiana Medicina di Laboratorio

Contrasto altoCaratteri grandi
 
 

norme CLSI-NCCLS in revisione

14/05/2006 03:19

Candidate for Advancement:
H43-A2, Flow Cytometric Analysis
H42-A2, Flow Cytometry
M41-P, Viral Culture;
POCT4-A2, Point-of-Care
POCT1-A2, Point-of-Care Connectivity
AUTO10-P, Autoverification
AUTO11-P, IT Security
C24-A3, Statistical Quality Control
H20-A2, Leukocyte Differential

Candidate for Advancement:
H43-A2, Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline—Second Edition
H42-A2, Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline—Second Edition
M41-P, Viral Culture; Proposed Guideline
POCT4-A2, Point-of-Care In Vitro Diagnostic (IVD) Testing; Approved Guideline—Second Edition
POCT1-A2, Point-of-Care Connectivity; Approved Standard–-Second Edition
AUTO10-P, Autoverification of Clinical Laboratory Test Results; Proposed Guideline
AUTO11-P, IT Security of In Vitro Diagnostic Instruments and Software Systems; Proposed Standard
C24-A3, Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions; Approved Guideline—Third Edition
H20-A2, Reference Leukocyte Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard—Second Edition

Collegamenti associati



SIMeL, Via Ponchini 17/int.7 - 31033 Castelfranco Veneto (TV) - Tel. 0423 738098 - Fax 0423 740715 - P.IVA 02316020268 - C.F. 02052910284